<DOC>
	<DOC>NCT01033669</DOC>
	<brief_summary>Assessment of the inhalation profiles of four dry powder inhalers in patients with variable degrees of lung obstruction</brief_summary>
	<brief_title>Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction</brief_title>
	<detailed_description>Randomized to device sequence</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>Subjects with a physician documented history or diagnosis of asthma for at least 6 months Reversibility, defined as an increase in FEV1 at the Screening visit of greater than or equal to 12% and 200 mL Subjects with a physician documented history or diagnosis of mild or severe Chronic Obstructive Pulmonary Disease Female subjects who are pregnant Subjects who have a history of lifethreatening asthma/COPD or who have experienced two or more exacerbations requiring hospitalization in the 12 months prior to screening Evidence of lower respiratory tract infection Subjects diagnosed with pulmonary fibrosis, bronchiectasis, pneumoconiosis, sarcoidosis or tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Inhalation profiles</keyword>
	<keyword>asthma</keyword>
	<keyword>COPD</keyword>
</DOC>